HHGregg’s profit, revenue rise, but same-store sales fall
Indianapolis-based HHGregg boosted its fourth-quarter profit thanks to 42 stores that opened during 2010, off-setting decreased sales at retail locations operating for more than a year.
Public Companies
Articles
Analyst: Feds’ new rule may not sink ITT Educational, peers
Shares of for-profit education companies—including Carmel-based ITT Educational Services Inc.—ended higher on Tuesday as a William Blair analyst said a long-awaited federal "gainful employment" rule likely won't hurt vocational school chains as much as investors think.
Hoosiers finally score one of Foot Locker’s House of Hoops
Finish Line’s main competitor had bypassed Indianapolis at it chose locations for its concept store that sells Nike-brand basketball shoes and apparel.
WellPoint approves annual ‘say on pay’ measure
Shareholders of WellPoint Inc. approved on Tuesday the hefty pay packages of the company’s executives and voted for the right to weigh in annually on future executive compensation.
Eli Lilly’s slumbering stock finally shows signs of life
Is it finally time to get some growth again out of a stock that since its debut on the public market 59 years ago has minted thousands of millionaires?
Noble Roman’s first-quarter profit, revenue tick up
Revenue at Noble Roman's Inc. inched up in the first quarter as the Indianapolis-based franchisor continued to grow its take-and-bake pizza operation in grocery stores.
Kite Realty Trust reports wider first-quarter loss
Indianapolis-based Kite Realty Group Trust on Friday reported a wider first-quarter loss than a year ago thanks to declining revenue and a big dividend payment to preferred shareholders.
Auction services firm improves revenue, profit
The parent company of the Adesa auto auction firm more than quadrupled its first-quarter profit on revenue that increased 5 percent.
UPDATE: Republic Airways loses $22M on fuel, maintenance
Indianapolis-based Republic Airways Holdings Inc. said it lost $22.4 million during the first quarter on higher fuel and maintenance costs.
CNO Financial’s first-quarter profits surge 59 percent
The Carmel-based life and health insurer earned $54 million, or 19 cents per share, topping the expectations of Wall Street analysts.
Zimmer Holdings quarterly profit rises 2 percent
Warsaw-based orthopedic implant maker Zimmer Holdings Inc. said Thursday its first-quarter profit rose 2 percent on higher sales of reconstructive, dental and other products.
Dow AgroSciences reports record revenue
Indianapolis-based Dow AgroSciences on Thursday reported sales of $1.6 billion in its first quarter, up 17 percent from the same period last year due to higher volume and increased prices.
Court blocks generic versions of Lilly’s Cymbalta
Eli Lilly and Co. said Wednesday that a federal court is blocking low-cost generic versions of Cymbalta from the market until the patents supporting the drug expire.
Bell Industries turns annual profit
The holding company for Bell Techlogix and the Recreational Products Group earned a profit of $300,000 in 2010 after losing $1.9 million the previous year.
Celadon boosts financial performance
Celadon Group Inc. improved revenue and profit in its third fiscal quarter despite lower volumes attributed to bad weather, the Indianapolis-based trucking company said Tuesday.
WellPoint’s first-quarter profit soars above expectations
The Indianapolis-based health insurer earned $2.44 per share and raised its full-year profit forecast by 40 cents per share.
Profit, revenue up at Interactive Intelligence
The Indianapolis business-communications software firm on Monday reported revenue of $47.7 million in the quarter ended March 31, up 36 percent from the same period last year. Profit was $3.1 million.
Enrollment, profit fall at ITT Educational
The Carmel-based operator of for-profit colleges earned $85.4 million in the three months ended March 31, a 2.4-percent decline from the same quarter a year ago.
Analysts demand news on next Lilly blockbuster
Eli Lilly and Co. spends a lot of time these days telling the rest of the story—how well it’s doing in areas not connected to highly lucrative drugs about to see their patents expire. But for the most part, investors and analysts just want to know when the next blockbuster will be coming.
Charges drive down first-quarter profit at Lilly
First-quarter profit fell at Eli Lilly and Co. as the company recorded restructuring charges due to its downsizing and higher research costs as it tries to develop new drugs to help it shrug off its looming patent expirations.